Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Open Access Highly Access

Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients

Guo-Hao Xie, Xiang-Ming Fang*, Qiang Fang, Xin-Min Wu, Yu-Hong Jin, Jun-Lu Wang, Qu-Lian Guo, Miao-Ning Gu, Qiu-Ping Xu, Dong-Xin Wang, Shang-Long Yao, Shi-Ying Yuan, Zhao-Hui Du, Yun-Bo Sun, Hai-Hong Wang, Shui-Jing Wu and Bao-Li Cheng

Critical Care 2008, 12:R5 doi:10.1186/cc6766

Accesses  

  • Last 30 days: 72 accesses
  • Last year: 1383 accesses
  • All time: 8193 accesses

Cited by

BioMed Central: 3 citations

Commentary   Free

Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?

Yoav Golan Critical Care 2009, 13:180 (21 August 2009)

Abstract | Full text | PDF | PubMed

Research   Open Access

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation

Marya D Zilberberg, Smita Kothari, Andrew F Shorr Critical Care 2009, 13:R94 (19 June 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Letter   Free Highly Accessed

Discriminating invasive fungal infection from colonization

Stijn Blot, Koenraad Vandewoude, Dirk Vogelaers Critical Care 2008, 12:412 (3 April 2008)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations